GEP20043181B - Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies - Google Patents

Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies

Info

Publication number
GEP20043181B
GEP20043181B GEAP20006120A GEAP2000006120A GEP20043181B GE P20043181 B GEP20043181 B GE P20043181B GE AP20006120 A GEAP20006120 A GE AP20006120A GE AP2000006120 A GEAP2000006120 A GE AP2000006120A GE P20043181 B GEP20043181 B GE P20043181B
Authority
GE
Georgia
Prior art keywords
alkyl
optionally substituted
progesterone
treatment
aryl
Prior art date
Application number
GEAP20006120A
Other languages
English (en)
Inventor
James P Edwards
Lin Zhi
Andrew Fensome
Puwen Zhang
Mark A Collins
Christopher M Tegley
Todd K Jones
Jay E Wrobel
Eugene A Terefenko
Original Assignee
Wyeth Corp
Ligand Pharmaceuticals Inc Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by Wyeth Corp, Ligand Pharmaceuticals Inc Us filed Critical Wyeth Corp
Publication of GEP20043181B publication Critical patent/GEP20043181B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GEAP20006120A 1999-05-04 2000-05-01 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies GEP20043181B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
GEP20043181B true GEP20043181B (en) 2004-02-25

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP20006120A GEP20043181B (en) 1999-05-04 2000-05-01 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies

Country Status (24)

Country Link
EP (1) EP1175411B1 (https=)
JP (2) JP4958338B2 (https=)
KR (1) KR100732692B1 (https=)
CN (1) CN1131856C (https=)
AT (1) ATE386729T1 (https=)
AU (1) AU766801B2 (https=)
BG (1) BG65277B1 (https=)
BR (1) BR0010214A (https=)
CA (1) CA2371712C (https=)
CZ (1) CZ20013952A3 (https=)
DE (1) DE60038108T2 (https=)
DK (1) DK1175411T3 (https=)
EA (1) EA004511B1 (https=)
ES (1) ES2301482T3 (https=)
GE (1) GEP20043181B (https=)
HU (1) HUP0203332A3 (https=)
IL (1) IL146298A0 (https=)
MX (1) MXPA01011287A (https=)
NO (1) NO321370B1 (https=)
NZ (1) NZ515353A (https=)
PL (1) PL351083A1 (https=)
SG (1) SG120970A1 (https=)
SK (1) SK15922001A3 (https=)
TR (1) TR200103285T2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386729T1 (de) * 1999-05-04 2008-03-15 Wyeth Corp Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
ATE409699T1 (de) * 2004-04-08 2008-10-15 Wyeth Corp Verfahren zur minimierung von thioamidverunreinigungen
ATE413398T1 (de) * 2004-04-08 2008-11-15 Wyeth Corp Thioamidderivate als progesteronrezeptormodulatoren
EP1756072A2 (en) * 2004-04-27 2007-02-28 Wyeth Purification of progesterone receptor modulators
CA2562160C (en) * 2004-04-27 2013-05-28 Wyeth Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
WO2006014476A1 (en) * 2004-07-07 2006-02-09 Wyeth Cyclic progestin regimens and kits
SI1778710T1 (sl) 2004-08-13 2012-05-31 Wyeth Llc Derivati tanaprogeta metaboliti in njihove uporabe
EP1877059B8 (en) 2005-04-28 2010-05-19 Wyeth a Corporation of the State of Delaware Micronized tanaproget and compostions containing same
JP2008539254A (ja) * 2005-04-28 2008-11-13 ワイス タナプロゲットの精製形態
SI1896034T1 (sl) 2005-04-28 2010-07-30 Wyeth Llc Mikronizirani sestavki tanaprogeta in postopki priprave le-tega
WO2007030153A2 (en) * 2005-04-28 2007-03-15 Wyeth Compositions containing micronized tanaproget
BRPI0610433A2 (pt) * 2005-04-28 2010-11-23 Wyeth Corp forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada
CN103989687A (zh) * 2005-06-09 2014-08-20 惠氏公司 含有炔雌醇的tanaproget组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5696130A (en) * 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Tricyclic steroid receptor modulator compounds and methods
EP1043325B1 (en) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
ES2203790T3 (es) * 1996-10-02 2004-04-16 Bristol-Myers Squibb Pharma Company 1,4-dihidro-2h-3,1-benzoxacin-2-onas 4,4-disustituidas utiles como inhibidores de la transcriptasa reversa del hiv e intermedios y procedimientos para su preparacion.
ATE386729T1 (de) * 1999-05-04 2008-03-15 Wyeth Corp Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren
EP1877059B8 (en) * 2005-04-28 2010-05-19 Wyeth a Corporation of the State of Delaware Micronized tanaproget and compostions containing same
CN103989687A (zh) * 2005-06-09 2014-08-20 惠氏公司 含有炔雌醇的tanaproget组合物

Also Published As

Publication number Publication date
EA004511B1 (ru) 2004-04-29
JP4958338B2 (ja) 2012-06-20
SG120970A1 (en) 2006-04-26
BG106080A (en) 2002-05-31
CA2371712A1 (en) 2000-11-09
JP2012087129A (ja) 2012-05-10
PL351083A1 (en) 2003-03-10
BR0010214A (pt) 2002-02-13
ATE386729T1 (de) 2008-03-15
CN1131856C (zh) 2003-12-24
NZ515353A (en) 2004-03-26
KR100732692B1 (ko) 2007-06-27
IL146298A0 (en) 2002-07-25
CZ20013952A3 (cs) 2002-05-15
BG65277B1 (bg) 2007-11-30
ES2301482T3 (es) 2008-07-01
JP2002543192A (ja) 2002-12-17
AU4811900A (en) 2000-11-17
EP1175411B1 (en) 2008-02-20
DK1175411T3 (da) 2008-06-09
JP5523430B2 (ja) 2014-06-18
EP1175411A1 (en) 2002-01-30
NO20015381L (no) 2002-01-03
KR20020000170A (ko) 2002-01-04
TR200103285T2 (tr) 2002-02-21
CA2371712C (en) 2009-12-22
EA200101181A1 (ru) 2002-04-25
NO321370B1 (no) 2006-05-02
NO20015381D0 (no) 2001-11-02
DE60038108T2 (de) 2009-02-12
AU766801B2 (en) 2003-10-23
HUP0203332A2 (hu) 2003-01-28
DE60038108D1 (de) 2008-04-03
CN1349516A (zh) 2002-05-15
SK15922001A3 (sk) 2002-09-10
HUP0203332A3 (en) 2004-12-28
MXPA01011287A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
GEP20043181B (en) Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Composition Containing Them and Their Use for Treatment Progesterone-Related Maladies
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
HUP0300641A2 (hu) Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények
BR0109855A (pt) Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5
HUP9801688A2 (hu) Acetamidszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
HUP9900616A2 (hu) Triciklusos vegyületek, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
ATE204269T1 (de) Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
AR007440A1 (es) Compuestos triciclos fenilamino sustituidos y composiciones farmaceuticas de los mismos.
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
PL335696A1 (en) Substituted 4-arylmethylene-2-imino-2,3-dihydrothiasoles and their derivatives as well as their pharmaceutical application
BR0014901A (pt) Derivados de trifenil-alquenos e seu uso como moduladores de receptores seletivos de estrogênios
PL313075A1 (en) Heterocyclic compounds used as antagonistic substances in respect to neurokinin
EE03872B1 (et) Arüülglütsiinamiidi derivaadid, meetod nende valmistamiseks ja neid ühendeid sisaldavad farmatseutilised preparaadid
HUP9901096A2 (hu) Indolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
PL309281A1 (en) Derivatives of 1,4-benzodiazepine and their application as cck modulators
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
IL126278A0 (en) Novel 5-membered ring heterocycles their preparation their use and pharmaceutical preparations comprising them
NZ336189A (en) Diaza-spiro[3,5]nonane derivatives and use in treatment of diseases related to the orphanin receptor
YU75394A (sh) Anelirani dihidropiridini i njihova primena za pripremanje farmaceutskih preparata
ATE18221T1 (de) (1-arylcyclobutyl)(heterocyclyl)methylaminderivate, ihre herstellung und ihre verwendung als arzneimittel.
NZ515355A (en) Cyclocarbamate derivatives as progesterone receptor modulators
JPS6470412A (en) Medicinal composition